[A cross-sectional study of factors related to traditional Chinese medicine use for hospitalized acute coronary syndrome patients in China's level 2 hospitals].

Yifei Zhao(Peking University), Yangfeng Wu(Peking University), Lihong Ma, Yong Huo(Sun Yat-sen University), Xin Du, Shenshen Li(Peking University), Runlin Gao(Academy of Medical Sciences), Dayi Hu(Beihang University), Yihong Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
PubMed
February 1, 2014
Cited by 3

Related Papers

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
|New England Journal of Medicine|2013|603
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
|JAMA|2017|540
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
|JAMA|2022|342